[Company contact FOR RELEASE ON JULY 11, 2011 AT 8:30 a.m. EDT (NY) China Biologic Evaluating Possible Effects from a New Provincial Plan TAI’AN, China, July 11, 2011 /PRNewswire-Asia-FirstCall/ – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic,” or the “Company”), a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial Health Department has issued a “Plan] [Company Contact: China Biologic To Open Plasma Collection Station in Shandong Province -- TAI'AN, China, July 11, 2011 The Company received approval to build two new plasma collection stations in Yishui and Ningyang Counties in May 2010. The Yishui station began collecting plasma in December 2010. With the opening of the Ningyang station, China Biologic owns seven of the eight] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): July 11, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 (Former name or former address, if changed since]